Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$426K Buy
25,731
+9,921
+63% +$164K ﹤0.01% 973
2023
Q3
$357K Sell
15,810
-140
-0.9% -$3.97K ﹤0.01% 1011
2023
Q2
$510K Sell
15,950
-814
-5% -$26K ﹤0.01% 920
2023
Q1
$500K Sell
16,764
-708
-4% -$29.9K ﹤0.01% 939
2022
Q4
$823K Sell
17,472
-9,201
-34% -$468K ﹤0.01% 863
2022
Q3
$1.07M Sell
26,673
-486
-2% -$24.8K ﹤0.01% 843
2022
Q2
$1.03M Sell
27,159
-338
-1% -$12.3K ﹤0.01% 849
2022
Q1
$1.33M Sell
27,497
-2,047
-7% -$111K ﹤0.01% 866
2021
Q4
$1.87M Buy
+29,544
New +$2.33M ﹤0.01% 772

Other funds holding AGEN

Putnam Investments's AGEN Position: Q4 2023 in Review

Putnam Investments increased its Agenus (AGEN) stake by 63% in Q4 2023, buying an estimated $164K and bringing the position to 25,731 shares worth $426K. The position accounts for ﹤0.01% of the portfolio, ranked #973.

Putnam Investments first reported a position in AGEN in Q4 2021 and has held it in 9 quarters since. The position peaked at $1.87M in Q4 2021. 169 funds tracked by Wall St. Rank hold AGEN as of Q4 2023.

  • Putnam Investments held 25,731 shares of Agenus worth $426K as of Q4 2023.
  • Putnam Investments bought 9,921 Agenus shares in Q4 2023, an estimated $164K.
  • Agenus made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #973 holding.
  • Putnam Investments first reported a position in Agenus in Q4 2021 and has held it in 9 quarters since.
  • Putnam Investments's Agenus position peaked at $1.87M in Q4 2021.
  • 169 funds tracked by Wall St. Rank held Agenus as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.